Philadelphia-negative myeloproliferative neoplasms (MPNs), including essential thrombocythemia (ET), polycythemia vera (PV), and primary myelofibrosis (PMF), are hematologic malignancies characterized by the abnormal proliferation of blood

Dr. Ruben Mesa on his move to Wake Forest Baptist Comprehensive Cancer Center MPN patients are asking about your recent move from MD Anderson to

Just Published NUTRIENT Trial: Mediterranean Diet Intervention in MPNs The Mediterranean diet has long been associated with disease fighting anti-inflammatory benefits. In recent years, it

Advancing Research: Targeting the JAK2V617F Hematopoietic Stem Cell Through Integrins-Based Combination Early in her career, as a veterinarian, Shinobu Matsuura, DVM, PhD, remembers a debilitating

MPNs More Visible Than Ever at ASCO 2023  Recognized as the premier educational and scientific event for the greater oncology community, MPN presentations and posters

2023 European Hematology Congress MPN Highlights The European Hematology Association (EHA) Congress 2023 in Frankfurt, Germany in June, brought more than 10,000 participants together, with